Cost-Effectiveness of Rivaroxaban Versus Warfarin for Stroke Prevention in Nonvalvular Atrial Fibrillation in The Guangdong Healthcare Setting in China
Nov 1, 2016, 00:00 AM
10.1016/j.jval.2016.09.1762
https://www.valueinhealthjournal.com/article/S1098-3015(16)33128-X/fulltext
Section Title :
Disease-Specific Studies
Section Order :
1664
First Page :
A653
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)33128-X&doi=10.1016/j.jval.2016.09.1762